Vertex Pharmaceuticals
VRTX
VRTX
715 hedge funds and large institutions have $45.2B invested in Vertex Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 74 funds opening new positions, 279 increasing their positions, 243 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
0% less capital invested
Capital invested by funds: $45.2B → $45.2B (-$70M)
3% less funds holding
Funds holding: 735 → 715 (-20)
12% less first-time investments, than exits
New positions opened: 74 | Existing positions closed: 84
Holders
715
Holding in Top 10
15
Calls
$309M
Puts
$277M
Top Buyers
| 1 | +$420M | |
| 2 | +$326M | |
| 3 | +$254M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$239M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$98.3M |
Top Sellers
| 1 | -$438M | |
| 2 | -$231M | |
| 3 | -$105M | |
| 4 |
Jennison Associates
New York
|
-$83.6M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$78.2M |